✦ LIBER ✦

Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control

✍ Scribed by P. Anagnostis; V. G. Athyros; F. Adamidou; A. Panagiotou; M. Kita; A. Karagiannis; D. P. Mikhailidis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Emerging cardiovascular actions of the i

✍ David J Grieve; Roslyn S Cassidy; Brian D Green 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 435 KB

Glucagon-like peptide-1-based therapies:

✍ Alan J. Garber 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 176 KB

The potential role of glucagon-like pept

✍ J. Combes; S. Borot; F. Mougel; A. Penfornis 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 787 KB

Liraglutide, a once-daily human glucagon

✍ A. Garber; R. R. Henry; R. Ratner; P. Hale; C. T. Chang; B. Bode 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 971 KB

Improved glycaemic control with minimal

✍ K. Kaku; M. F. Rasmussen; P. Clauson; Y. Seino 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 595 KB